Prediction of Chronic Kidney Disease Following Pre-eclampsia: Diagnosis and Early Care

ConditionPreeclampsia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorCentre Hospitalier le Mans

About this trial

Pre-eclampsia (PE) is a pregnancy-associated syndrome of variable severity, classically defined by the combination of hypertension and proteinuria in a previously non-hypertensive or proteinuric patient. These symptoms normally resolve within 2-3 months after delivery regardless of the severity of the pre-eclampsia.

Regardless of its definition, preeclampsia is associated with an increased risk of obstetric events and, for the mother, an increased risk of developing chronic kidney disease (CKD), hypertension, diabetes and cardiovascular disease in the broad sense.

The relationship between preeclampsia and Chronic Kidney Disease is, however, complex and not fully understood.

Investigator proposes an interventional study to identify the diagnosis of Chronic Kidney Disease in patients who have developed an episode of Preeclampsia.

Eligibility criteria

Qualifiers

Meeting the preeclampsia criteria or one of its complications (eclampsia, HELLP syndrome) according to the ISSHP 2018 definitions within the last 5 years

Having signed the informed consent

Person affiliated to social security

Disqualifiers

Patient with mental disability or language barrier preventing understanding of the study or consent

Person deprived of liberty by judicial or administrative decision

Person under forced psychiatric care

Person subject to a legal protection measure

Trial design

Treatments tested in this trial

  • annual follow-up during 10 years

Treatment groups

400 Participants
are divided into 1 treatment group

Sponsors and collaborators